Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

remsss

Gilead facing criticism for charging $2,340 for remdesivir

June 30, 2020
Manufacturing and Production COVID-19, coronavirus

Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has …

News

Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme

June 29, 2020
Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine

Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …

News
chinese_army

China’s COVID-19 vaccine candidate approved for military use

June 29, 2020
Sales and Marketing COVID-19, coronavirus

China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …

News
boots

70% of BAME pharmacists in the UK have had no risk assessment for COVID-19

June 26, 2020
Medical Communications COVID-19, coronavirus

More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, …

News
remdesivir_ulrich_perrey

Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19

June 26, 2020
Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir

In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …

News
top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …

News
shutterstock_2

AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership

June 25, 2020
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …

News
antibody_tests

COVID-19 antibody tests are being used by the NHS without proper assessment, experts warn

June 25, 2020
Business Services, Research and Development COVID-19, antibodies, antibody, coronavirus

Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …

News
fauci

NIH ordered to cancel coronavirus research funding by White House, Dr Fauci tells Congress

June 25, 2020
Business Services COVID-19, Fauci, NIH, coronavirus, pandemic

The National Institutes of Health had its funding cut from a research project into bat coronavirus, according its Director Dr …

News
3806537611_b006ec40bf_c

UK health leaders urge “rapid review” of COVID-19 preparedness as England relaxes lockdown

June 24, 2020
Research and Development COVID-19, England, UK, coronavirus

British Prime Minister Boris Johnson announced an extensive rollback of existing lockdown measures to restrict the spread of COVID-19 in …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 24, 2020
Research and Development COVID, COVID-19, coronavirus

Coronavirus news this week sees treatments for existing diseases being tested in COVID-19 patients, with Roche’s rheumatoid arthritis drug Actemra …

News
vaccinesss_1

Sanofi expects approval for its COVID-19 vaccine by the start of 2021

June 23, 2020
Manufacturing and Production COVID-19, coronavirus

Sanofi has said it expects to have its coronavirus vaccine approved by the start of next year which is faster …

News
gilead-sciences

Gilead to investigate inhaled formulation of promising COVID-19 therapy remdesivir

June 23, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, remdesivir

Gilead is intent on pushing the applications of its antiviral drug remdesivir after it has shown efficacy in the treatment …

News
fda

FDA and EMA agree to intensify collaboration during COVID-19 pandemic

June 23, 2020
Manufacturing and Production COVID-19, coronavirus

Senior officials from the US Food and Drug Administration and the European Medicines Agency have pledged to continue working closely …

News
pexels-photo-3044623_araruna

How is COVID-19 impacting the rare disease community?

June 22, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …

Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026